Industry News
-
Bayer’s new heart drug Vericiguat is approved in China
On May 19, 2022, China’s National Medical Products Administration (NMPA) approved the marketing application for Bayer’s Vericiguat (2.5 mg, 5 mg, and 10 mg) under the brand name Verquvo™. This drug is used in adult patients with symptomatic chronic heart failure and redu...Read more -
On April 15, 2022, the pilot production of Lecardipine hydrochloride main ring was completed at one time, and the current production capacity is 5Mt/ month.
On April 15, 2022, the pilot production of Lecardipine hydrochloride main ring was completed at one time, and the current production capacity is 5Mt/ month. English Name: Lercanidipine hydrochloride Chemical name: 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedi...Read more